...
首页> 外文期刊>Frontiers in Bioengineering and Biotechnology >Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery
【24h】

Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery

机译:基质金属蛋白酶-2损害猪再灌注心肌梗死冠状动脉内递送间充质干细胞的归巢:与心肌内细胞递送的比较。

获取原文
           

摘要

Background. Intracoronary injection of mesenchymal stem cells (MSCs) resulted in a prompt decrease of absolute myocardial blood flow (AMF) with late and incomplete recovery of myocardial tissue perfusion. Here we investigated the effect of decreased AMF on oxidative stress marker matrix metalloproteinase-2 (MMP-2) and its influence on the fate and homing and paracrine character of MSCs after intracoronary or intramyocardial cell delivery in a closed-chest reperfused myocardial infarction model in pigs. Methods. Porcine MSC were transiently transfected with Ad-Luc and Ad-GFP. One week after MI, the GFP-Luc-MSCs were injected either intracoronary (group IC, 11.00±1.07 x106) or intramyocardially (group IM, 9.88±1.44 x106). AMF was measured before, immediately after, and 24h post GFP-Luc-MSC delivery. In vitro bioluminescence signal was used to identify tissue samples containing GFP-Luc-MSCs. Myocardial tissue MMP-2 and CXCR4 receptor expression (index of homing signal) were measured in bioluminescence positive and negative infarcted and border, and non-ischemic myocardial areas one-day post cell transfer. At 7-day follow-up, myocardial homing (cadherin, CXCR4, SDF-1alpha) and angiogenic (FGF2, VEGF) were quantified by ELISA of homogenized myocardial tissues from the bioluminescence positive and negative infarcted and border, and non-ischemic myocardium. Biodistribution of the implanted cells was quantified by using Luciferase assay and confirmed by fluorescence immunochemistry. Global left ventricular ejection fraction was measured at baseline and one-month post cell therapy using MRI. Results. AMF decreased immediately after intracoronary cell delivery, while no change in tissue perfusion was found in the IM group (42.6±11.7 vs. 56.9±16.7 ml/min, p=0.018). Intracoronary delivery led to a significant increase in myocardial MMP-2 64 kD expression (448±88 vs. 315±54 intensity*mm^2, p=0.021), and decreased expression of CXCR4 (592±50 vs. 714±54 pg/tissue/ml, p=0.006), with significant exponential decay between MMP-2 and CXCR4 (r=0.679, p<0.001). FGF2 and VEGF of the bioluminescence infarcted and border zone of homogenized tissues were significantly elevated in the IM goups as compared to IC group. LVEF increase was significantly higher in IM group (0.8±8.4 vs 5.3±5.2 %, p=0.046) at the 1-month follow up. Conclusions. Intracoronary stem cell delivery decreased AMF, with consequent increase in myocardial expression of MMP-2 and reduced CXCR4 expression with lower level of myocardial homing and angiogenic.
机译:背景。冠状动脉内注射间充质干细胞(MSCs)导致心肌绝对绝对血流量(AMF)迅速下降,心肌组织灌注的恢复较晚且不完全。在这里,我们研究了在封闭胸腔再灌注心肌梗死模型中,AMF降低对氧化应激标记物基质金属蛋白酶-2(MMP-2)的影响及其对冠状动脉内或心肌细胞递送后MSC命运,归巢和旁分泌特性的影响。猪。方法。用Ad-Luc和Ad-GFP瞬时转染猪MSC。 MI后1周,GFP-Luc-MSCs被冠状动脉内注射(IC组,11.00±1.07×106)或心肌内注射(IM组,9.88±1.44×106)。在递送GFP-Luc-MSC之前,之后和之后24小时测量AMF。体外生物发光信号用于鉴定含有GFP-Luc-MSC的组织样品。细胞转移后一天,在生物发光阳性和阴性梗塞和边界以及非缺血性心肌区域测量心肌组织MMP-2和CXCR4受体表达(归巢信号指数)。在第7天的随访中,通过ELISA对来自生物发光的正,负梗死和边界以及非缺血性心肌的均质化心肌组织进行ELISA定量心肌归巢(钙黏着蛋白,CXCR4,SDF-1alpha)和血管生成(FGF2,VEGF)。植入的细胞的生物分布通过使用荧光素酶测定法进行定量,并通过荧光免疫化学证实。在基线和细胞治疗后一个月使用MRI测量总体左心室射血分数。结果。冠状动脉内细胞递送后,AMF立即降低,而IM组未发现组织灌注变化(42.6±11.7 vs. 56.9±16.7 ml / min,p = 0.018)。冠状动脉内递送导致心肌MMP-2 64 kD表达显着增加(448±88对315±54强度* mm ^ 2,p = 0.021),并降低了CXCR4的表达(592±50对714±54 pg) /组织/ml,p=0.006),在MMP-2和CXCR4之间有明显的指数衰减(r = 0.679,p <0.001)。与IC组相比,IM组的生物发光梗死和均质组织边界区的FGF2和VEGF显着升高。在1个月的随访中,IM组的LVEF升高明显更高(0.8±8.4 vs 5.3±5.2%,p = 0.046)。结论。冠状动脉内干细胞递送降低了AMF,因此MMP-2的心肌表达增加,而CXCR4的表达降低,心肌归巢和血管生成水平降低。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号